Related Experiment Video
Updated: Feb 26, 2026

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
Published on: June 3, 2020
Parkinson's disease with mild cognitive impairment: severe cortical thinning antedates dementia
Carmen Gasca-Salas1,2,3, Daniel García-Lorenzo4, David Garcia-Garcia1,2,5,6
1Neurosciences Area, CIMA, Department of Neurology and Neurosurgery, Clínica Universidad de Navarra, University of Navarra, Pamplona, Spain.
Abstract:
Mild cognitive impairment (MCI) in Parkinson's disease (PD) is a risk factor for dementia and thus, it is of interest to elucidate if specific patterns of atrophy in PD-MCI patients are associated with a higher risk of developing dementia. We aim to define pattern(s) of regional atrophy in PD-MCI patients who developed dementia during 31 months of follow-up using cortical thickness analysis Twenty-three PD-MCI patients and 18 controls underwent brain MRI and completed a neuropsychological examination at baseline, PD-MCI patients were followed after a 31 month follow-up in order to assess their progression to dementia. At follow up, 8 PD-MCI patients had converted to dementia (PD-MCI converters) whereas 15 remained as PD-MCI (PD-MCI non-converters). All patients were at least 60 years old and suffered PD ≥ 10 years. There were no baseline differences between the two groups of patients in clinical and neuropsychological variables. The cortex of PD-MCI converters was thinner than that of PD-MCI non-converters, bilaterally in the frontal, insula and the left middle temporal areas, also displaying a more widespread pattern of cortical thinning relative to the controls. This study shows that aged and long-term PD patients with MCI who convert to dementia in the short-mid term suffer a thinning of the cortex in several areas (frontal cortex, and middle temporal lobe and insula), even when their cognitive impairment was similar to that of PD-MCI non-converters. Thus, MRI analysis of cortical thickness may represent a useful measure to identify PD-MCI patients at a higher risk of developing dementia.
Insights
Parkinson's disease with mild cognitive impairment (PD-MCI) patients who develop dementia show significant cortical thinning in frontal, insula, and temporal areas. This MRI finding may help identify individuals at higher risk for dementia progression.
Area of Science:
- Neurology
- Neuroimaging
- Cognitive Science
Background:
- Mild cognitive impairment (MCI) in Parkinson's disease (PD) is a significant risk factor for dementia.
- Identifying PD-MCI patients at high risk for dementia progression is crucial for timely intervention.
Purpose of the Study:
- To investigate patterns of regional brain atrophy in PD-MCI patients who converted to dementia within 31 months.
- To determine if cortical thickness differences at baseline predict dementia conversion in PD-MCI.
Main Methods:
- Cortical thickness analysis using MRI in 23 PD-MCI patients and 18 controls.
- Longitudinal follow-up over 31 months to assess dementia conversion.
- Comparison of baseline MRI and neuropsychological data between PD-MCI converters and non-converters.
Main Results:
- PD-MCI patients who converted to dementia (PD-MCI converters) exhibited thinner cortex bilaterally in frontal, insula, and left middle temporal areas compared to non-converters.
- Cortical thinning was more widespread in PD-MCI converters relative to controls.
- No significant baseline clinical or neuropsychological differences were observed between converters and non-converters.
Conclusions:
- Short-to-mid-term dementia progression in PD-MCI is associated with specific patterns of cortical thinning.
- MRI-based cortical thickness analysis can serve as a valuable tool for identifying PD-MCI patients at elevated risk of dementia.
- Early identification of at-risk individuals can facilitate targeted therapeutic strategies.
Related Concept Videos
Parkinson's Disease: Overview
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Dementia
The progression of dementia is generally gradual....
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Neural Regulation
Alzheimer's Disease: Treatment

